187 related articles for article (PubMed ID: 20055819)
1. Febrile ulceronecrotic Mucha-Habermann disease: a rare dermatological emergency.
Helbling I; Chalmers RJ; Yates VM
Clin Exp Dermatol; 2009 Dec; 34(8):e1006-7. PubMed ID: 20055819
[No Abstract] [Full Text] [Related]
2. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
Sotiriou E; Patsatsi A; Tsorova C; Lazaridou E; Sotiriadis D
Acta Derm Venereol; 2008; 88(4):350-5. PubMed ID: 18709304
[TBL] [Abstract][Full Text] [Related]
3. Febrile ulceronecrotic Mucha-Habermann disease.
Luo DQ
Cutis; 2013 Nov; 92(5):E9-E12. PubMed ID: 24343222
[No Abstract] [Full Text] [Related]
4. Febrile ulceronecrotic Mucha-Habermann disease with extensive skin necrosis in intertriginous areas.
Yang CC; Lee JY; Chen W
Eur J Dermatol; 2003; 13(5):493-6. PubMed ID: 14693498
[TBL] [Abstract][Full Text] [Related]
5. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
Suárez J; López B; Villalba R; Perera A
Dermatology; 1996; 192(3):277-9. PubMed ID: 8726649
[TBL] [Abstract][Full Text] [Related]
6. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha.
Tsianakas A; Hoeger PH
Br J Dermatol; 2005 Apr; 152(4):794-9. PubMed ID: 15840118
[TBL] [Abstract][Full Text] [Related]
7. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) presenting as Stevens-Johnson syndrome.
Kaufman WS; McNamara EK; Curtis AR; Kosari P; Jorizzo JL; Krowchuk DP
Pediatr Dermatol; 2012; 29(2):135-40. PubMed ID: 22084981
[TBL] [Abstract][Full Text] [Related]
8. High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease.
Marenco F; Fava P; Fierro MT; Quaglino P; Bernengo MG
Dermatol Ther; 2010; 23(4):419-22. PubMed ID: 20666830
[TBL] [Abstract][Full Text] [Related]
9. [Febrile ulceronecrotic Mucha-Habermann disease].
Dupin A; Bosset D; Atger L; Chevallier B; Saiag P; Benoist G
Arch Pediatr; 2016 Jan; 23(1):82-5. PubMed ID: 26552626
[TBL] [Abstract][Full Text] [Related]
10. Febrile ulceronecrotic Mucha-Habermann disease in an 8-year-old boy responding to methotrexate.
Alratrout J; Alshammasi F; Ansari N
Int J Dermatol; 2016 Nov; 55(11):1205-1209. PubMed ID: 27368714
[TBL] [Abstract][Full Text] [Related]
11. Febrile ulceronecrotic Mucha-Habermann disease: a case with systemic symptoms managed with subcutaneous methotrexate.
Lin CY; Cook J; Purvis D
Australas J Dermatol; 2012 Nov; 53(4):e83-6. PubMed ID: 23157793
[TBL] [Abstract][Full Text] [Related]
12. [Febrile ulceronecrotic Mucha-Habermann disease].
Arellano Lorca J; Yáñez Silva I; Soto Vilches F; Luna Heine A; Corredoira Salum Y
Rev Med Chil; 2016 Sep; 144(9):1214-1217. PubMed ID: 28060985
[TBL] [Abstract][Full Text] [Related]
13. Febrile ulceronecrotic Mucha-Habermann disease in a 34-month-old boy: a case report and review of the literature.
Perrin BS; Yan AC; Treat JR
Pediatr Dermatol; 2012; 29(1):53-8. PubMed ID: 21906156
[TBL] [Abstract][Full Text] [Related]
14. Febrile ulceronecrotic Mucha-Habermann's disease with pulmonary involvement.
Zhang LX; Liang Y; Liu Y; Ma L
Pediatr Dermatol; 2010; 27(3):290-3. PubMed ID: 20609148
[TBL] [Abstract][Full Text] [Related]
15. Self-limited variant of febrile ulceronecrotic Mucha-Habermann disease with polyclonal T-cell receptor rearrangement.
Helmbold P; Gaisbauer G; Fiedler E; Stücker M; Wolter M; Marsch WCh
J Am Acad Dermatol; 2006 Jun; 54(6):1113-5. PubMed ID: 16713489
[No Abstract] [Full Text] [Related]
16. Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with atypical cells.
Rivera R; Ortiz P; Rodriguez-Peralto JL; Vanaclocha F; Iglesias L
Int J Dermatol; 2003 Jan; 42(1):26-8. PubMed ID: 12581137
[No Abstract] [Full Text] [Related]
17. Febrile ulceronecrotic Mucha-Habermann disease after levamisole-adulterated cocaine use: an unusual case.
Fongue J; Amatore F; Benzaquen M; Spadari M; Granel B; Berbis P
Clin Exp Dermatol; 2018 Oct; 43(7):846-848. PubMed ID: 29851134
[No Abstract] [Full Text] [Related]
18. Febrile ulceronecrotic Mucha-Habermann disease mimicking Kawasaki disease.
Weins AB; Theiler M; Bogatu B; Kerl K; Pleimes M; Pachlopnik-Schmid J; Weibel L
J Dtsch Dermatol Ges; 2020 Feb; 18(2):140-142. PubMed ID: 31814284
[No Abstract] [Full Text] [Related]
19. [Febrile ulceronecrotic Mucha-Habermann disease with exuberant mucosal involvement: case report].
Cumming MM; Salathiel AS; Paino MA; Delort S; Roselino AM
An Bras Dermatol; 2009; 84(6):655-8. PubMed ID: 20191178
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease.
Pyrpasopoulou A; Athyros VG; Karagiannis A; Chrysomallis F; Zamboulis C
Dermatology; 2007; 215(2):164-5. PubMed ID: 17684382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
